A newly funded medical device startup had successfully proven its technology concept but lacked the internal resources to navigate the complexities of Quality Management, Regulatory Affairs, and Technical Documentation. Building a robust Quality Management System (QMS) from scratch would have diverted precious time and funding from core product development. Instead, the company chose Zamann Pharma Support’s “Quality as a Service” model, which allowed them to join Zamann’s existing QMS framework within two months.
Through this approach, the startup leveraged Zamann’s MDR-compliant procedures, established infrastructure, and regulatory expertise. Costs were far lower than assembling an entire QMS independently, and the startup also shortened its product registration timelines significantly. The successful launch has led the company to maintain a close collaboration with Zamann, outsourcing the bulk of their QA and regulatory obligations to take advantage of the ongoing benefits of this unique partnership.
“Zamann Pharma Support’s ‘Quality as a Service’ model changed the game for our startup. We were able to integrate into their QMS swiftly, saving both time and money. The direct access to consultants and the MDR-ready pipeline helped us bring our product to market faster, and we continue to rely on Zamann’s expertise for ongoing QA and regulatory needs.”